Viewing Study NCT03991403


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-01-02 @ 5:55 AM
Study NCT ID: NCT03991403
Status: UNKNOWN
Last Update Posted: 2023-04-03
First Post: 2019-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module